• Login
    View Item 
    •   Shocker Open Access Repository Home
    • Graduate Student Research
    • GRASP: Graduate Research and Scholarly Projects
    • Proceedings 2022: 18th Annual Symposium on Graduate Research and Scholarly Projects
    • View Item
    •   Shocker Open Access Repository Home
    • Graduate Student Research
    • GRASP: Graduate Research and Scholarly Projects
    • Proceedings 2022: 18th Annual Symposium on Graduate Research and Scholarly Projects
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Epidermolysis Bullosa: An overview of current and future potential treatment options

    View/Open
    abstract (47.55Kb)
    Date
    2022-04-29
    Author
    Howard, Mackenzie
    Tanner, Bradley
    Trood, Ashley
    Advisor
    Hanneman, Ronda
    Metadata
    Show full item record
    Citation
    Howard, M.; Tanner, B.; Trood, A. 2022. Epidermolysis Bullosa: An overview of current and future potential treatment options -- In Proceedings: 18th Annual Symposium on Graduate Research and Scholarly Projects. Wichita, KS: Wichita State University
    Abstract
    Epidermolysis Bullosa (EB) is a rare inherited condition of which the most common clinical finding is blistering and erosions of the skin following minor trauma. While this is the most well-known manifestation of EB, there are many other complications, including: gastrointestinal malabsorption, various genitourinary fusions of skin, glomerulonephritis, contractures and fusions of joints, dental abnormalities, corneal scarring, respiratory tract scarring, skin cancer, and cutaneous infections, which can sometimes lead to sepsis and eventually death. EB consists of four main classifications, and 34 distinct subtypes. The four classifications are Epidermolysis Bullosa Simplex (EBS), Junctional Epidermolysis Bullosa (JEB), Dystrophic Epidermolysis Bullosa (DEB), and Kindler Epidermolysis Bullosa (KEB). These classes are distinguished by the layer of skin in which the formation of blisters occurs: EBS is formed in the intraepidermal layer, JEB is formed in the lamina lucida of the basement membrane, DEB is formed below the basement membrane, and Kindler's EB can involve multiple or all these layers. Treatment for EB until recently has largely been supportive care, focusing on symptom management and proper nutritional support. Treatments that are appearing now include gene therapy, stem cell therapy, and placental-based therapies. Gene therapy involves the actual splicing of affected genes that are responsible for adhesions of skin layers associated with certain types of EB. Stem cell and placental-based therapies focus more on regenerating skin for the EB patient, although studies are ongoing. Research continues for treatments to combat this rare genetic disease.
    Description
    Presented to the 18th Annual Symposium on Graduate Research and Scholarly Projects (GRASP) held at the Rhatigan Student Center, Wichita State University, April 29, 2022

    Research completed in the Department of Physician Assistant, College of Health Professions
    URI
    https://soar.wichita.edu/handle/10057/23510
    Collections
    • PA Graduate Student Conference Papers
    • Proceedings 2022: 18th Annual Symposium on Graduate Research and Scholarly Projects

    Browse

    All of Shocker Open Access RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsBy TypeThis CollectionBy Issue DateAuthorsTitlesSubjectsBy Type

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    DSpace software copyright © 2002-2022  DuraSpace
    DSpace Express is a service operated by 
    Atmire NV